London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lidco Group Plc will be holding an investor presentation on Tuesday 13 October 2015 at Rocket, 6 Adams Court, Old Broad Street, London, EC4N 1DX from 4.45pm for a 5.00pm start. The presentation will be followed by drinks and canapés. This is the first event that the new CEO, Matt Sassone, will be presenting at. If you would like to register to attend the presentation, or require further information, please contact Lianne Cawthorne on +44(0)20 7933 8788 or email lidco@walbrookpr.com.
for me to slip back into LID for afew pennies for Christmas Ship x yo ho ho xxx santa
"Matt Sassone, Chief Executive Officer of LiDCO, commented: "I am extremely pleased to be taking over as Chief Executive Officer from Terry O'Brien to lead the Company at this very exciting phase of its growth. LiDCO has reported two consecutive years of profitable trading and I look forward to delivering further growth and value to shareholders. The handover period with Terry has given me a clear insight into the opportunities for the Company. I look forward to advising shareholders how we intend to take the Company to the next level of growth in the near future."
everyone has long lives in Japan - why do they need so much monitoring - why r we not targeting overweight people in dubai
plenty of need for heart monitoring over there - in fact I'll email Lidco and ask them
http://www.lidco.com/investor/news/2015/06-05-15.php Looks like an excellent choice to me.
I'm not sure they are 'banging on' as much as reporting relevant information, and as they say Japan is a conservative market and Lidco gained approval from Japanese authorities three years ago. Japan is also very big market. The recent announcement was that LiDCOrapid V2 Unity software had been cleared for sale in Japan, and that Lidco believe this expands its product offering and differentiates it from its competitor. I'm not sure how you reach the conclusion the company is 'clearly' not being pushed to the front, but hey ho, if you're not convinced about the company's earnings potential then if I were you I wouldn't invest.
Not sure why they are banging on about the latest model to Japan when they have had no sales to Japan and they are up against an entrenched competitor. I'm not convinced the future earnings looking too good here. They clearly aren't being pushed to the front by their Japan distributor.
PS - given the price rise today on the back of a buy of just 100,000 tells me yesterday's two trades of 975,000 were 1 or 2. If it was 2, it suggests a market maker is quietly amassing stock, rather than bidding it up.
It could (1) be cross-trade, someone maybe transferring from one account to another. Or (2) there could be a buyer out there because ordinarily the bid price would move down, given current limited activity, by more than an .05, on the heels of a sale of close to one million. It could of course be (3) that the buyers of the two identical amounts were not the same market maker, but in fact the the same seller, in which case the seller would be not disclosing his total amount but hoodwinking market makers, but if that was the case I would have expected more of an adjustment downwards in the bid price, than the 9pence and 9.05 paid, as usually sellers who try to pull the wool over dealers' eyes are known to the market. My hunch is it was 1 or 2. ATB
two huge trades yesterday...probably sells ?
tucking his shares away.
I think it's more to do with time horizon, and that some folk saw Lidco on the leader board, galluping up 80% in a day or so, and jumped on the bandwagon. For them movement and quickly is important, and when a share is too quiet and steady they get out. I think that happened with a few today. They will come back, when there is movement again. I was pleased to see that Old Mutual increased their holding to over 12 million shares. I think some others will follow their lead, as Lidco has stayed the course - still around after 14 years and going from strength to strength. I suspect they are on the radar of bigger fish looking to acquire a few jewels in the medical crown, but hope that will not happen yet, with the price this low. ATB
I am comfortable here as well, folk don't seem to like companies that make profit and have no debt.
I think some who bought recently were waiting to see if the RNS would trigger another chunk of buys, and when it didn't materialise they sold. The big fall in price in early February was due entirely to one investor needing to sell some investments, which included circa 5million shares in Lidco, but the reasons were totally unrelated to Lidco. The amounts traded over the last few weeks are tiny as compared to shares in issue, and it doesn't take much - at the moment - to push the price of this share down. I've owned Lidco for over 10 years, and am comfortable with the fundamentals.
40k buy from yesterday just popped up.
what an opportunity...aim is mental at times
On two good RNS's...crazy
making profit...not even halfway to year high !
Commenting on the results Terry O'Brien, Chief Executive Officer, said: "LiDCO has now reported two consecutive years of profitable trading. We are now debt free, well-funded and expect to be cash generative in the current financial year. We have a strong position in our domestic market coupled with a growing surgery disposables business both domestically and in export territories. "We can expect 2015/16 to be our third successive year of profits. We are well resourced and organised for further growth through our direct sales organisation in the UK and increasingly see wider opportunities for growth with distribution partners."
LIDCOrapid v2 with continuous non-invasive blood pressure cleared for sale in Japan LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, announces the LiDCOrapidv2 with Unity software and continuous non-invasive blood pressure module have been cleared for sale in Japan. LiDCO's Unity software allows the connection of LiDCO's continuous non-invasive blood pressure monitoring module. Existing LiDCOrapid monitors can be easily upgraded to provide the new functionality. LiDCO believes that the availability of the Company's Unity software and continuous non-invasive blood pressure module will double the numbers of surgery patients suitable for monitoring with LiDCO's technology. Japan is the second largest market in the world for hemodynamic monitoring. The Company estimates that there are approximately 680,000 high-risk surgical patients per annum in Japan who can now benefit clinically from improved intraoperative fluid management. Commenting, Terry O'Brien, Chief Executive Officer of LiDCO, said: "We expect the availability of this new product to significantly expand the market potential for sales of our monitors and associated high margin disposables in Japan. With this registration we believe that our non-invasive monitor can now address fluid and drug management across the entire surgical patient pathway without the insertion of minimally invasive arterial catheters."
not one RNS but two...excellent.
Goes quickly..last hour.
Book your seats...if good 11p open